Transactions & Finance

Carlyle Group invests in blood management business MAK-SYSTEM

The Carlyle Group has announced a “significant investment” in MAK-SYSTEM (MAK), a family-owned company providing healthcare software for the management of blood, plasma, tissue and cells products.
Jonathan Zafrani

© Leaders League

The Carlyle Group has announced a “significant investment” in MAK-SYSTEM (MAK), a family-owned company providing healthcare software for the management of blood, plasma, tissue and cells products.


In conjunction with Carlyle’s investment, MAK shareholders have decided to name Philippe Houssiau as CEO.


Founded in 1984 by Simon Kiskovski, MAK provides software for the blood chain management process, from donation through to transfusion.


A Carlyle Group statement said the investment will provide MAK with additional capital to support the company’s global growth strategy and to continue innovating for the blood service, plasma collector and hospital markets.


Equity for the transaction comes from Carlyle Europe Partners V (CEP V), a European-focused upper-mid market buyout fund, as well as from Carlyle Europe Technology Partners IV (CETP IV), a pan-European and US fund focusing on growth-oriented investments in telecoms, media and technology. No further financial details were disclosed.


Kiskovski said: “We are delighted at the opportunity to be working with Carlyle, one of the most predominant investors in the healthcare space. This partnership will enable us to better serve our clients and rapidly extend our footprint with numerous innovations.”


Jonathan Zafrani (pictured), managing director at The Carlyle Group, said: “MAK is a very successful, high-quality company, which has established strong capabilities. We are delighted to be working alongside the Kiskovski family and Philippe Houssiau to support the future growth of the company, through product innovation and further international expansion. This investment demonstrates how Carlyle seeks to support companies by leveraging a combination of sector expertise – in this case, healthcare and technology, and our international scale across the world.”


Philippe Houssiau, CEO of MAK, said: “MAK is a true leader and a pioneer in its field; I look forward to working with the MAK team, Carlyle and the Kiskovski family in taking the business to its next phases of development.”

 

interview

Accenture's CEO and CFO interview by Leaders League Group

About us

Download